95 results
Page 3 of 5
6-K
EX-99.1
tim9sway9tl091wj gw
30 May 23
Report of Foreign Private Issuer
8:02am
6-K
EX-99.1
6odi95p00x lv1
30 May 23
Entitlement Offer of Loyalty Options
8:00am
6-K
EX-99.1
mytit42nvgj15e84zo2
5 May 23
Report of Foreign Private Issuer
6:06am
6-K
EX-99.1
cz6mwy p858
2 May 23
Incannex Announces Final Results from Phase 1 Clinical Trial Assessing Safety and Pharmacokinetics of IHL-675A
12:00am
6-K
EX-99.1
s57mqynt
13 Apr 23
Incannex Appoints QPS to Advance CannQuit-N™ (Nicotine), CannQuit-O™ (Opioid) and Renecann™ Products in the USA and EU
9:23pm
6-K
EX-99.1
m14wisiemp3t7
5 Dec 22
Report of Foreign Private Issuer
6:01am
6-K
EX-99.1
q0fx8ho4owa2em0p
28 Nov 22
Incannex Engages Eurofins to Manufacture ReneCann Therapeutic Topical Application for Immune Disordered Skin Diseases
8:19pm
6-K
EX-99.1
3a12e7 pvxygo1
25 Nov 22
Incannex Engages Eurofins to Manufacture Novel Addiction Treatments CannQuit-N and CannQuit-O
6:08am
6-K
EX-99.1
myss24d ku
17 Nov 22
Report of Foreign Private Issuer
6:01am
20-F
bbnck
28 Oct 22
Annual report (foreign)
6:31am
20-F
EX-4.11
8achr
28 Oct 22
Annual report (foreign)
6:31am
6-K
EX-99.1
qf0cdq
11 Oct 22
Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-216A for Treatment of Concussion and Traumatic Brain Injury
6:15am
6-K
EX-99.1
qpapi v2sb
7 Oct 22
Notice of date of Annual General Meeting
6:03am
6-K
EX-99.1
oe45jb4 76
19 Sep 22
Report of Foreign Private Issuer
9:38pm
6-K
EX-99.1
juwqp
8 Sep 22
Incannex to Participate in the Prestigious H.C. Wainwright 24th Annual Global Investment Conference
6:04am
6-K
EX-99.1
qg2jsrppf vsi
6 Sep 22
Incannex Included in the S&P/ASX 300 Index
6:01am
6-K
EX-99.1
t9dig4kgdsssqw8br
1 Sep 22
Report of Foreign Private Issuer
6:13am
6-K
EX-99.1
86se75hn8yp7pu
17 Aug 22
Incannex Appoints FDA Regulatory Affairs Expert Mr Robert B. Clark to the Board of Directors
6:04am
6-K
EX-99.1
dbp79z6axg0os od
9 Aug 22
Report of Foreign Private Issuer
6:01am
6-K
EX-99.1
8hhqbwpv76dbzkd
4 Aug 22
Report of Foreign Private Issuer
8:32pm